UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial

Nature medicine, 2022-05, Vol.28 (5), p.939-945

2022

Volltextzugriff (PDF)

Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603)

JNCI cancer spectrum, 2020-02, Vol.4 (1), p.pkz088-pkz088

2020

Volltextzugriff (PDF)

Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non–Small-Cell Lung Cancer (NS-NSCLC): A Trial of the ECOG-ACRIN Cancer Research Group (E6508)

Clinical lung cancer, 2020-11, Vol.21 (6), p.520-526

2020

Volltextzugriff (PDF)

Clinical Utility of Genomic Recurrence Risk Stratification in Early, Hormone-Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Real-World Experience

Clinical breast cancer, 2023-02, Vol.23 (2), p.155-161

2023

Volltextzugriff (PDF)

Extrapulmonary small cell carcinoma: the University of Kansas experience and review of literature

Medical oncology (Northwood, London, England), 2014-10, Vol.31 (10), p.187-187, Article 187

2014

Volltextzugriff (PDF)

Prospective clinical evaluation of blood-based tumor mutational burden (bTMB) as a predictive biomarker for atezolizumab (atezo) in 1L non-small cell lung cancer (NSCLC): Interim B-F1RST results

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.12001-12001

2018

Volltextzugriff (PDF)

Metastasis of Benign Leiomyomas Outside the Uterus

Kansas journal of medicine, 2018-05, Vol.11 (2), p.1-58

2018

Volltextzugriff (PDF)

Androgen Mediation—and Antiandrogens Mitigation—of the Epidermal Growth Factor Receptor (EGFR) Inhibitor–Induced Rash: Results From a Pilot Randomized Trial and Small Translational Case Series

American journal of hospice & palliative medicine, 2019-06, Vol.36 (6), p.519-525

2019

Volltextzugriff (PDF)

Blastic Plasmacytoid Dendritic Cell Neoplasm: A Rapidly Progressive and Fatal Disease without Aggressive Intervention

Clinical Medicine Insights: Case Reports, 2013-01, Vol.2013 (2013), p.201-204

2013

Volltextzugriff (PDF)

Real-world safety and discontinuation rates of fam-trastuzumab deruxtecan in advanced HER2-positive and HER2-low cancer

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e12518-e12518

2024

Volltextzugriff (PDF)

Undiagnosed Systemic Lupus Erythematosus Presenting as Hemophagocytic Lymphohistiocytosis

Case reports in rheumatology, 2015-01, Vol.2015 (2015), p.1-3

2015

Volltextzugriff (PDF)

Liquid Biopsy-based Precision Therapy in Patients with Advanced Solid Tumors: A Real-world Experience from a Community-based Oncology Practice

The oncologist (Dayton, Ohio), 2022-03, Vol.27 (3), p.183-190

2022

Volltextzugriff (PDF)

Clinical utility of genomic recurrence risk stratification in early, hormone receptor–positive, human epidermal growth factor receptor 2–negative breast cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.546-546

2022

Volltextzugriff (PDF)

Liquid biopsy testing: Impact on treatment assignment and survival in a community-based oncology practice—A real-world experience

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.3027-3027

2021

Volltextzugriff (PDF)

Liquid biopsy: A community-based oncology practice experience

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.3527-3527

2020

Volltextzugriff (PDF)

The application of next-generation sequencing in the community clinical oncology setting

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e23145-e23145

2016

Volltextzugriff (PDF)

Metastasis of Benign Leiomyomas Outside the Uterus

Kansas journal of medicine, 2019-01, Vol.11 (2), p.56-58

2019

Volltextzugriff (PDF)

ABOUND.70+: Safety and efficacy of nab -paclitaxel/carboplatin ( nab -P/C) in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.9059-9059

2017

Volltextzugriff (PDF)

APF530 (granisetron injection extended-release) in a three-drug regimen for delayed CINV in highly emetogenic chemotherapy

Future oncology (London, England), 2016-06, Vol.12 (12), p.1469-1481

2016

Volltextzugriff (PDF)

Blastic Plasmacytoid Dendritic Cell Neoplasm: A Rapidly Progressive and Fatal Disease without Aggressive Intervention

Clinical medicine insights. Case reports, 2013-12, Vol.2013 (6), p.201-204

2013

Volltextzugriff (PDF)

APF530 versus ondansetron, each in a guideline-recommended three-drug regimen, for the prevention of chemotherapy-induced nausea and vomiting due to anthracycline plus cyclophosphamide-based highly emetogenic chemotherapy regimens: a post hoc subgroup analysis of the Phase III randomized MAGIC trial

Cancer management and research, 2017-01, Vol.9, p.179-187

2017

Volltextzugriff (PDF)

Extramedullary progression of multiple myeloma despite concomitant medullary response to multiple combination therapies and autologous transplant: a case report

Journal of medical case reports, 2014-09, Vol.8 (1), p.299-299, Article 299

2014

Volltextzugriff (PDF)

Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report of a Rare Leukemic Variant

Journal of Clinical and Medical Case Reports, 2020-04, p.1-3

2020

Volltextzugriff (PDF)

Metastasis of Benign Leiomyomas Outside the Uterus

Kansas journal of medicine, 2018, Vol.11 (2), p.1-11

2018

Volltextzugriff (PDF)

Blastic Plasmacytoid Dendritic Cell Neoplasm: A Rapidly Progressive and Fatal Disease without Aggressive Intervention

Clinical medicine insights. Case reports, 2013, Vol.6, p.201-204

2013

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(42)
Berichte
(2)

Sprache

Englisch
(44)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Oncology
(15)
Humans
(14)
Male
(11)
Middle Aged
(10)
Female
(8)
Adult
(7)
Aged
(7)
Aged, 80 And Over
(5)
Cancer Therapies
(5)
Chemotherapy
(5)
Tumors
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Biological And Medical Sciences
(4)
Lung Neoplasms - Pathology
(4)
Medical Sciences
(4)
Patients
(4)
Prognosis
(4)
Quality Of Life
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial

Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603)

Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non–Small-Cell Lung Cancer (NS-NSCLC): A Trial of the ECOG-ACRIN Cancer Research Group (E6508)

Clinical Utility of Genomic Recurrence Risk Stratification in Early, Hormone-Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Real-World Experience

Extrapulmonary small cell carcinoma: the University of Kansas experience and review of literature

Prospective clinical evaluation of blood-based tumor mutational burden (bTMB) as a predictive biomarker for atezolizumab (atezo) in 1L non-small cell lung cancer (NSCLC): Interim B-F1RST results

Metastasis of Benign Leiomyomas Outside the Uterus

Androgen Mediation—and Antiandrogens Mitigation—of the Epidermal Growth Factor Receptor (EGFR) Inhibitor–Induced Rash: Results From a Pilot Randomized Trial and Small Translational Case Series

Blastic Plasmacytoid Dendritic Cell Neoplasm: A Rapidly Progressive and Fatal Disease without Aggressive Intervention

Real-world safety and discontinuation rates of fam-trastuzumab deruxtecan in advanced HER2-positive and HER2-low cancer

Undiagnosed Systemic Lupus Erythematosus Presenting as Hemophagocytic Lymphohistiocytosis

Liquid Biopsy-based Precision Therapy in Patients with Advanced Solid Tumors: A Real-world Experience from a Community-based Oncology Practice

Clinical utility of genomic recurrence risk stratification in early, hormone receptor–positive, human epidermal growth factor receptor 2–negative breast cancer

Liquid biopsy testing: Impact on treatment assignment and survival in a community-based oncology practice—A real-world experience

Liquid biopsy: A community-based oncology practice experience

The application of next-generation sequencing in the community clinical oncology setting

Metastasis of Benign Leiomyomas Outside the Uterus

ABOUND.70+: Safety and efficacy of nab -paclitaxel/carboplatin ( nab -P/C) in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC)

APF530 (granisetron injection extended-release) in a three-drug regimen for delayed CINV in highly emetogenic chemotherapy

Blastic Plasmacytoid Dendritic Cell Neoplasm: A Rapidly Progressive and Fatal Disease without Aggressive Intervention

APF530 versus ondansetron, each in a guideline-recommended three-drug regimen, for the prevention of chemotherapy-induced nausea and vomiting due to anthracycline plus cyclophosphamide-based highly emetogenic chemotherapy regimens: a post hoc subgroup analysis of the Phase III randomized MAGIC trial

Extramedullary progression of multiple myeloma despite concomitant medullary response to multiple combination therapies and autologous transplant: a case report

Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report of a Rare Leukemic Variant

Metastasis of Benign Leiomyomas Outside the Uterus

Blastic Plasmacytoid Dendritic Cell Neoplasm: A Rapidly Progressive and Fatal Disease without Aggressive Intervention

Suchergebnisse filtern